Hair loss drug litfulo under Real-World watch in 3,000 patients
NCT ID NCT07152119
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 34 times
Summary
This study is tracking the safety and effects of the medicine Litfulo in 3,000 adults and teens with severe alopecia areata, a condition causing major hair loss. Participants take the drug as prescribed by their doctor, and researchers monitor side effects and hair regrowth over time. This is an observational study, not a cure, and patients will need to keep taking the medication to control their condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.